China Diagnostic Reagent Industry 2012-2014: Market Size, Share, Analysis, Growth, Trends and Forecast Research Report Available Online by ResearchMoz

ResearchMoz includes new market research report "China Diagnostic Reagent Marke Report, 2012-2014: Industry Analysis, Growth, Size, Shares and Forecast " to its huge collection of research reports. Click here to download detail report - http://www.researchmoz.us/china-diagnostic-reagent-industry-report-2012-2014-report.html.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
ResearchMoz

ResearchMOZ

China Diagnostic Reagent Industry 2012-2014: Market Size, Share, Analysis, Growth, Trends and Forecast Research Report Available Online By ResearchMoz

Albany, NY (PRWEB) October 12, 2013

Chinas diagnostic reagent industry has formed a certain market scale and basis, and is marching from the introduction stage to the growth stage. With the continuous growth in Chinas medical care investment and per capita health care spending, the Chinas diagnostic reagent market has a promising prospect.

In vitro diagnostic reagents account for more than 90.0% of the output of Chinas diagnostic reagent industry. In 2011, the market scale of in vitro diagnostic reagents reached about RMB 11.4 billion in China, the industry will maintain a growth rate of 15%-20% in the future, and the market scale will hit RMB 20.8 billion in 2015.

View Full Report With TOC @ http://www.researchmoz.us/china-diagnostic-reagent-industry-report-2012-2014-report.html

At present, there are only a few integrated in vitro diagnostic reagent enterprises with strong strength in Chinas diagnostic reagent market, including KHB and Fosun Pharma; other enterprises such as Da An Gene, BioSino, Leadman and Livzon have competitive advantages in specific fields such as biochemical diagnosis, immunodiagnosis, and molecular diagnosis. Meanwhile, Chinas in vitro diagnostic reagent industry concentration is low. Among 300-400 enterprises, there are only about 20 enterprises with annual sales of more than RMB 100 million. The enterprises are generally small and have a few product varieties. In 2011, KHB, Da An Gene, BioSino, Leadman only occupied 3.8%, 2.3%, 1.9%, 1.6% of the market respectively.

As a high-tech industry, the profitability of the overall Chinese diagnostic reagent industry is high. In 2011, among major Chinese diagnostic reagent enterprises, KHB, Da An Gene, BioSino, Kinghawk, Livzon, Leadman all achieved a gross margin of more than 50%; Fosun Pharma reached a gross margin of 40.4%, since diagnostic reagent and instrument business accounts for a lower proportion of its revenue. With the improvement of industry concentration, its expected that the advantageous enterprises with strong capability of technological innovation and large production scale will obtain higher market share and profitability.

Browse Other Reports By Research In China - http://www.researchmoz.us/publisher/research-in-china-67.html

China Diagnostic Reagent Industry Report, 2012-2014 mainly includes the following contents:

Market scale, market structure, import and export, competitive landscape, profitability, entry barriers of Chinas diagnostic reagent industry;
Regulatory system and policy, industry policy, industrial chain, upstream and downstream of Chinas diagnostic reagent industry;
Development forecast of Chinas diagnostic reagent industry, including the forecast of market scale, major market segments, industry competition, and enterprise development trends;
Production, operation, investment, M&A, diagnostic reagent business and development prospect of 15 Chinese diagnostic reagent enterprises.

Related Reports:

Global and China In-vitro Diagnostic Reagent Industry, 2013-2017

China's population accounts for more than 20% of the world's population, while the market share of invitro diagnostics is less than 5% of the world's; in 2012, the annual consumption per capita of China's invitro diagnostic products was less than USD 2, while that of developed countries reached USD 25 to USD 30. Therefore, there is a wide growth space for China's invitro diagnostics. CRI predicts that the growth rate of the market scale of China's invitro diagnostics will be markedly higher than the global average level and the CAGR will maintain over 15% from 2013 to 2017. By 2017, the market scale will reach CNY 30 billion, among which immune and biochemical products will continually occupy most of the market share, while the proportion of molecular products will relatively increase. During the upgrading of products in the future and the process of domestic substitution, the industry concentration rate will grow. Click Here To Download Detail Report - http://www.researchmoz.us/research-report-on-global-and-china-in-vitro-diagnostic-reagent-industry-2013-2017-report.html

Diagnostic Reagent Markets in China

China's demand for diagnostic reagent has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled. Click Here To Download Detail Report - http://www.researchmoz.us/diagnostic-reagent-markets-in-china-report.html

China Monoclonal Antibody Diagnostic Reagents Industry 2013

2013 Market Research Report on China Monoclonal Antibody Diagnostic Reagents Industry
was professional and depth research report on China Monoclonal Antibody Diagnostic Reagents industry.

Chapter Two Monoclonal Antibody Diagnostic Reagents International and China Market Analysis
2.1 Monoclonal Antibody Diagnostic Reagents Industry International Market Analysis
2.1.1 Monoclonal Antibody Diagnostic Reagents International Market Development History
2.1.2 Monoclonal Antibody Diagnostic Reagents Product and Technology Developments
2.1.3 Monoclonal Antibody Diagnostic Reagents Competitive Landscape Analysis
2.1.4 Monoclonal Antibody Diagnostic Reagents International Key Countries Development Status
2.1.5 Monoclonal Antibody Diagnostic Reagents International Market Development Trend
2.2 Monoclonal Antibody Diagnostic Reagents Industry China Market Analysis

Click Here To Download Detail Report - http://www.researchmoz.us/china-monoclonal-antibody-diagnostic-reagents-industry-2013-market-research-report-report.html

About Us:

ResearchMoz (http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales(at)researchmoz(dot)us

Visit Blog @ http://chinaresearchreporton.blogspot.com/.